Hsbc Holdings PLC Rocket Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$26.16 - $30.74 $210,535 - $247,395
8,048 New
8,048 $216,000
Q3 2022

Nov 14, 2022
BUY
$12.37 - $18.41 $141,166 - $210,094
11,412 New
11,412 $177,000
Q4 2019

Feb 14, 2020
SELL
$11.07 - $24.23 $118,305 - $258,946
-10,687 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$10.85 - $14.78 $115,953 - $157,953
10,687 New
10,687 $125,000

Others Institutions Holding RCKT

# of Institutions
209
Shares Held
93.2M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $890M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email